Gastrointestinal Cytomegalovirus Disease Secondary to Measles in an Immunocompetent Infant
Overview
Overview
Journal
World J Gastroenterol
Publisher
Baishideng Publishing Group
Specialty
Gastroenterology
Date
2021 Jul 29
PMID
34321857
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Yang reported an immunocompetent infant with gastrointestinal cytomegalovirus disease secondary to measles infection. We express our opinion about the diagnosis and treatment of this rare disease.
References
1.
Mayo-Wilson E, Imdad A, Herzer K, Yakoob M, Bhutta Z
. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ. 2011; 343:d5094.
PMC: 3162042.
DOI: 10.1136/bmj.d5094.
View
2.
Huiming Y, Chaomin W, Meng M
. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005; (4):CD001479.
PMC: 7076287.
DOI: 10.1002/14651858.CD001479.pub3.
View
3.
Canpolat C, Culbert S, Gardner M, Whimbey E, Tarrand J, Chan K
. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1996; 17(4):589-93.
View
4.
Jackson B, Black R
. Available studies fail to provide strong evidence of increased risk of diarrhea mortality due to measles in the period 4-26 weeks after measles rash onset. BMC Public Health. 2017; 17(Suppl 4):783.
PMC: 5688494.
DOI: 10.1186/s12889-017-4745-2.
View
5.
Misin A, Antonello R, Di Bella S, Campisciano G, Zanotta N, Giacobbe D
. Measles: An Overview of a Re-Emerging Disease in Children and Immunocompromised Patients. Microorganisms. 2020; 8(2).
PMC: 7074809.
DOI: 10.3390/microorganisms8020276.
View